Showing results (1-10 of 616) with videos related to
Sort By:
Pageof 62
Blood|July 25, 2022
Avapritinib for advanced systemic mastocytosisJason Gotlib, Andreas Reiter, Daniel J DeAngeloBlood|February 28, 2020
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosisAndreas Reiter, Tracy I George, Jason GotlibExpert Opinion on Biological Therapy|October 16, 2020
Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurinJason Gotlib, Hanneke C Kluin-Nelemans, Cem Akin, et al.Expert Review of Hematology|August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematologyPeter Valent, Wolfgang R Sperr, Karl Sotlar, et al.The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.Hematology. American Society of Hematology. Education Program|November 24, 2005
The treatment of adolescents and young adults with acute lymphoblastic leukemiaDaniel J DeAngeloHematology/Oncology Clinics of North America|October 15, 2009
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphomaDaniel J DeAngeloHematology. American Society of Hematology. Education Program|December 6, 2015
The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemiaDaniel J DeAngeloJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Tailored Approaches to Induction Therapy for Acute Promyelocytic LeukemiaDaniel J DeAngeloPageof 62